New findings on the treatment of acute ischemic stroke
A study co-led by Prof. Jan Gralla and Prof. Urs Fischer provides important insights into the combination of treatments for acute ischemic stroke, specifically focusing on intravenous thrombolysis and endovascular treatment. The study was published in The Lancet recently.
Patients with acute ischemic stroke require immediate medical attention. Current international guidelines recommend that eligible patients should receive a combination of intravenous thrombolysis, a medication that can dissolve the clot causing the stroke but also carries a risk of intracranial bleeding, together with endovascular treatment, a procedure that mechanically removes the clot. However, the additional value of intravenous thrombolysis in patients directly admitted to endovascular treatment-capable centers has been a subject of debate. The recent study provides valuable data for this scientific debate.
Prof. Dr. Jan Gralla, Department of Diagnostic and Interventional Neuroradiology, and Prof. Dr. Urs Fischer, Stroke Research Center Bern